| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |